Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group.
Company has been founded since 2001 and occupied 100,000 m2 floor spaces. Company has RMB 48
million registered capital and plan to have a total investment of RMB 200 million.
Company has 202 employees at present, in which there are 81 employees with Bachelor’s Degree or
above, 19 employees with Master’s Degree or above. The sum of all different kinds of professional
talents has occupied over 72% of the total employees.
Jiangsu Zhongbang mainly produces special chemical materials such as Zinc Pyrithione and Copper
Pyrithione, and also pharmaceutical materials such as Telmisartan, Esomeprazole Magnesium
Trihydrate, Esomeprazole Magnesium pellets.
Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one
GMP plant for solid finished products. There are four production lines in API GMP plants with annual
capacity of 100 tons API. There are equipments for tablets, capsules and granules in solid finished
products.
Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentification both around 2017.